Burning Rock Biotech Limited
BNR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -11.4% | 11.6% | 5.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.1% | 72.8% | 73.2% | 71% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -2.5% | 0.9% | -11.4% | -37.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -12.7% | -6.5% | -10.1% | -64.5% |
| EPS Diluted | -15.6 | -9 | -12.5 | -78.7 |
| % Growth | -73.3% | 28% | 84.1% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |